Astrana Health (NASDAQ:ASTH – Get Free Report) had its target price dropped by equities researchers at Stifel Nicolaus from $50.00 to $45.00 in a report released on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the stock. Stifel Nicolaus’ price target points to a potential upside of 27.33% from the company’s current price.
A number of other analysts have also commented on the company. Jefferies Financial Group initiated coverage on Astrana Health in a report on Monday, February 26th. They set a “buy” rating and a $50.00 price target on the stock. Truist Financial boosted their price target on shares of Astrana Health from $41.00 to $44.00 and gave the stock a “hold” rating in a report on Friday, March 1st.
Get Our Latest Stock Report on ASTH
Astrana Health Price Performance
Astrana Health (NASDAQ:ASTH – Get Free Report) last posted its earnings results on Tuesday, May 7th. The company reported $0.31 EPS for the quarter, missing the consensus estimate of $0.32 by ($0.01). Astrana Health had a return on equity of 11.52% and a net margin of 4.49%. The business had revenue of $404.36 million for the quarter, compared to the consensus estimate of $413.84 million. During the same period in the previous year, the firm earned $0.42 earnings per share. The company’s revenue was up 19.9% on a year-over-year basis. As a group, sell-side analysts predict that Astrana Health will post 1.65 EPS for the current year.
About Astrana Health
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Featured Articles
- Five stocks we like better than Astrana Health
- Roth IRA Calculator: Calculate Your Potential Returns
- How to Read an Earnings Report | Step by Step Guide with Tips
- The 3 Best Retail Stocks to Shop for in August
- Datadog: In the Doghouse or Pullback to the Buyzone?
- What is the Shanghai Stock Exchange Composite Index?
- Celsius Stock’s Post-Earnings Morning Dip, Better than Coffee
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.